Published in Clin Infect Dis on May 22, 2012
Prevalence of skin problems and leg ulceration in a sample of young injecting drug users. Harm Reduct J (2014) 0.98
Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010. Emerg Infect Dis (2014) 0.87
Determinants and Drivers of Infectious Disease Threat Events in Europe. Emerg Infect Dis (2016) 0.85
Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UK. Emerg Infect Dis (2014) 0.84
Spatiotemporal Clustering Analysis and Risk Assessments of Human Cutaneous Anthrax in China, 2005-2012. PLoS One (2015) 0.82
New insights into gastrointestinal anthrax infection. Trends Mol Med (2014) 0.81
Injectional anthrax infection due to heroin use induces strong immunological memory. J Infect (2014) 0.81
Whole genome protein microarrays for serum profiling of immunodominant antigens of Bacillus anthracis. Front Microbiol (2015) 0.75
Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction (2003) 4.36
Meta-analysis of drug-related deaths soon after release from prison. Addiction (2010) 3.96
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol (2012) 2.24
Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology (2005) 1.91
A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006. Addiction (2012) 1.88
Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland. Stat Med (2013) 1.74
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology (2011) 1.68
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (2012) 1.62
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis (2013) 1.61
High-fluence and high-density treatment of perioral rhytides using a new, fractionated 2,790-nm ablative erbium-doped Yttrium Scandium Gallium Garnet Laser. Dermatol Surg (2011) 1.60
Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol (2005) 1.53
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol (2011) 1.50
Outcomes of Single-Ventricle Patients Supported With Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med (2016) 1.42
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis (2013) 1.38
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol (2014) 1.37
Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates. Addict Res Theory (2012) 1.29
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.23
Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (2012) 1.18
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction (2009) 1.18
Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg (2002) 1.17
Estimating current injectors in Scotland and their drug-related death rate by sex, region and age-group via Bayesian capture--recapture methods. Stat Methods Med Res (2008) 1.12
A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg (2004) 1.07
Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study. Int J Drug Policy (2011) 1.05
Prior information in behavioral capture-recapture methods: demographic influences on drug injectors' propensity to be listed in data sources and their drug-related mortality. Am J Epidemiol (2005) 1.03
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res (2008) 1.03
The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol (2006) 1.03
Radiofrequency in cosmetic dermatology: a review. Dermatol Surg (2012) 1.00
Dermal fillers: complications and informed consent. J Cosmet Laser Ther (2005) 1.00
Topical anesthetics for cosmetic and laser dermatology. J Drugs Dermatol (2005) 0.99
Failure of the fontan circulation. Heart Fail Clin (2014) 0.99
Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg (2006) 0.98
Missing targets on drugs-related deaths, and a Scottish paradox. Int J Drug Policy (2009) 0.98
Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther (2004) 0.98
Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg (2007) 0.97
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons. BMJ Open (2013) 0.95
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy (2012) 0.95
Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg (2008) 0.95
Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol (2012) 0.94
Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J Hepatol (2012) 0.94
Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Dermatol Surg (2003) 0.93
Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000-01. Lancet (2003) 0.93
Laser lipolysis of the arm, with and without suction aspiration: clinical and histologic changes. J Cosmet Laser Ther (2009) 0.93
Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis (2013) 0.93
Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther (2005) 0.92
How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. BMJ Qual Saf (2011) 0.91
A prospective study of fractional scanned nonsequential carbon dioxide laser resurfacing: a clinical and histopathologic evaluation. Dermatol Surg (2009) 0.90
Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther (2008) 0.90
Ablative skin resurfacing. Curr Probl Dermatol (2011) 0.90
Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg (2004) 0.90
Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow. Harm Reduct J (2008) 0.90
Clinical comparison of four hair removal lasers and light sources. J Cosmet Laser Ther (2006) 0.90
Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg (2013) 0.89
Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. J Cosmet Laser Ther (2006) 0.89
Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol (2009) 0.89
Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg (2006) 0.87
Radiofrequency in Cosmetic Dermatology: An Update. J Drugs Dermatol (2015) 0.87
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol (2009) 0.86
Supplemental tube feeding does not mitigate weight loss in infants with shunt-dependent single-ventricle physiology. Pediatr Cardiol (2013) 0.86
Recent advances in laser dermatology. J Cosmet Laser Ther (2009) 0.86
308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg (2003) 0.85
Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects. Pediatr Cardiol (2014) 0.85
Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol (2004) 0.85
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. Eur J Gastroenterol Hepatol (2012) 0.84
A review of sutures and other skin closure materials. J Cosmet Laser Ther (2010) 0.84
Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. J Cosmet Laser Ther (2011) 0.83
Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther (2012) 0.83
Controlled volumetric heating of subcutaneous adipose tissue using a novel radiofrequency technology. Lasers Surg Med (2009) 0.83
Cardiovascular disease and air pollution in Scotland: no association or insufficient data and study design? BMC Public Health (2012) 0.83
Trends in the incidence of HIV in Scotland, 1988-2009. Sex Transm Infect (2011) 0.83
Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine (2004) 0.82
Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg (2003) 0.82
Evaluation of a new super-long-pulsed 810 nm diode laser for the removal of unwanted hair: the concept of thermal damage time. Dermatol Surg (2002) 0.82
Electrosurgical resurfacing: a clinical, histologic, and electron microscopic evaluation. Lasers Surg Med (2003) 0.82
Digital photography, confidentiality, and teledermatology. Arch Dermatol (2004) 0.81
Laser hair removal pearls. J Cosmet Laser Ther (2008) 0.81
Suture material in cosmetic cutaneous surgery. J Cosmet Laser Ther (2007) 0.81
Safety and efficacy of fractional bipolar radiofrequency treatment in Fitzpatrick skin types V-VI. J Cosmet Laser Ther (2012) 0.80
Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg (2010) 0.80
Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg (2010) 0.80
Multicenter study comparing shunt type in the norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging (2013) 0.80
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology (2013) 0.79